IDYA - IDEAYA Biosciences, Inc.
33.03
-1.650 -4.995%
Share volume: 664,634
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$34.68
-1.65
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-04-2024 | 02-18-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 02-17-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 7.000 M | 0.000 | 0.000 | 207.834 M | 10.876 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 7.000 M | 0.000 | 0.000 | 207.834 M | 10.876 M | |
| nan% | nan% | inf% | -100.00% | nan% | inf% | -94.77% | |||
| Operating expenses | 51.017 M | 64.927 M | 66.893 M | 151.138 M | 84.389 M | 88.806 M | 99.382 M | 105.446 M | |
| Selling general and admin | 8.212 M | 10.394 M | 9.741 M | 10.955 M | 13.503 M | 14.580 M | 16.389 M | 18.847 M | |
| Research and development | 42.805 M | 54.533 M | 57.152 M | 140.183 M | 70.886 M | 74.226 M | 82.993 M | 86.599 M | |
| Total expenses | 51.017 M | 64.927 M | 66.893 M | 151.138 M | 84.389 M | 88.806 M | 99.382 M | 105.446 M | |
| 27.27% | 3.03% | 125.94% | -44.16% | 5.23% | 11.91% | 6.10% | |||
| Operating income | -51.017 M | -64.927 M | -66.893 M | -144.138 M | -84.389 M | -88.806 M | 108.452 M | -94.570 M | |
| Ebit | -39.572 M | -64.927 M | -66.893 M | -144.138 M | -72.178 M | -88.806 M | 108.452 M | -94.570 M | |
| Pretax income | -39.572 M | -64.927 M | -66.893 M | -155.583 M | -72.178 M | -88.806 M | 108.452 M | -61.166 M | |
| 64.07% | 3.03% | 132.58% | -53.61% | 23.04% | -222.12% | -156.40% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -39.572 M | -52.772 M | -51.821 M | -130.312 M | -72.178 M | -77.491 M | 119.244 M | -83.273 M | |
| -33.36% | 1.80% | -151.47% | 44.61% | -7.36% | 253.88% | -169.83% |